GlassScriptPhysician profile
Carlos Sanchez
NPI 1902802713
$1,764.31
in general payments reported to CMS, 2019-2025
14 companies · $268 in 2025
The $268 reported for 2025 was more than what 87% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $485 · 2020: $54.45 · 2021: $96.24 · 2022: $323 · 2023: $315 · 2024: $222 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $805.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radiometer America, INC | $375.00 | 2019 | |
| Novo Nordisk INC | $323.89 | 2020-2024 | Sogroya, Norditropin, Wegovy |
| Astrazeneca Pharmaceuticals LP | $322.42 | 2024-2025 | Airsupra, Andexxa |
| Boston Scientific Corporation | $180.50 | 2022-2023 | Eluvia |
| Mallinckrodt Hospital Products INC. | $138.00 | 2023 | Acthar |
| Abbvie INC. | $125.23 | 2021-2023 | Avycaz, Dalvance |
| Edwards Lifesciences Corporation | $51.48 | 2025 | Pascal |
| Allergan, INC. | $51.28 | 2019 | |
| Impulse Dynamics (USA) INC. | $51.15 | 2023 | Optimizer |
| Pfizer INC. | $42.35 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $36.87 | 2019-2021 | |
| Viiv Healthcare Company | $31.00 | 2025 | Apretude |
| Medline Industries LP | $17.92 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.